Furthermore, erlotinib 51, featuring a quinazoline moiety, acts as a pyroptotic agent by initiating the pyroptosis process in lung and various other tumor cells through the stimulation of caspase-1, caspase-4, caspase-5, and caspase-11 [165, 166]. This evidence concerns the gene CASP1 and neoplasm.